PetMed Express (PETS) Stock Price, News & Analysis

Company Overview

PetMed Express, Inc., doing business as PetMeds, is a direct-to-consumer pet pharmacy and online retailer. The company sells prescription and nonprescription medications, flea and tick treatments, vitamins and supplements, prescription diets, and other health products for dogs, cats, and other companion animals.

PetMeds offers products through its website and other direct-order channels, providing pet owners with access to medications and supplies that may be recommended or prescribed by veterinarians. Its business model is focused on convenience, home delivery, and recurring purchases for ongoing pet-health needs.

Founded in 1996, PetMed Express is headquartered in Delray Beach, Florida, and primarily serves customers in the United States. The company operates under the PetMeds and 1-800-PetMeds brands and is traded on the Nasdaq under the symbol PETS.

Key Stats

• Today's Range: $1.33 to $1.37
• 50-Day Range: $1.36 to $2.03
• 52-Week Range: $1.33 to $4.10
• Volume: 185,182 shs
• Average Volume: 303,714 shs
• Market Capitalization: $29.48 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $1.40
• Consensus Rating: Strong Sell

PetMed Express Stock Analysis - MarketRank™

PetMed Express scored higher than 21% of companies evaluated by MarketBeat, and ranked 413th out of 475 stocks in the consumer discretionary sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.3 / 5
• Analyst Rating: Strong Sell

Consensus Rating

PetMed Express has received a consensus rating of Strong Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 3 sell ratings.

Upside/Downside

The consensus price target for PetMed Express is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

PetMed Express has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for PetMed Express are expected to grow in the coming year, from ($0.50) to ($0.35) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of PetMed Express is -0.99, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of PetMed Express is -0.99, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

PetMed Express has a P/B Ratio of 1.01. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.66% of the float of PetMed Express has been sold short.

Short Interest Ratio / Days to Cover

PetMed Express has a short interest ratio ("days to cover") of 6.79.

Change versus previous month

Short interest in PetMed Express has recently decreased by 12.12%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

PetMed Express does not currently pay a dividend.

Dividend Growth

PetMed Express does not have a long track record of dividend growth.

News and Social Media

• Score: 1.5 / 5
• News Sentiment: 0.40

News Sentiment

PetMed Express has a news sentiment score of 0.40. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Consumer Discretionary companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for PetMed Express this week, compared to 2 articles on an average week.

Search Interest

Only 1 people have searched for PETS on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, PetMed Express insiders have not sold or bought any company stock.

Percentage Held by Insiders

1.30% of the stock of PetMed Express is held by insiders.

Percentage Held by Institutions

73.33% of the stock of PetMed Express is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/13/2026
• Today: 10/02/2026
• Next Earnings (Estimated): 10/13/2026
• Fiscal Year End: 3/31/2027

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Consumer Discretionary
• Industry: Specialty Retail
• Sub-Industry: Other Specialty Retail
• Current Symbol: NASDAQ:PETS
• CIK: 1040130
• Web: www.petmeds.com
• Phone: (561) 426-4444
• Fax: 561-526-4445
• Employees: 189
• Year Founded: 1996

Price Target and Rating

• Average Price Target for PetMed Express: $1.40
• High Price Target: $1.40
• Low Price Target: $1.40
• Potential Upside/Downside: +2.9%
• Consensus Rating: Strong Sell
• Rating Score (0-4): 1.00
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.38)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$57.29 million
• Net Margins: -17.34%
• Pretax Margin: -17.38%
• Return on Equity: -91.69%
• Return on Assets: -35.15%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.68
• Quick Ratio: 0.47

Sales & Book Value

• Annual Sales: $179.02 million
• Price / Sales: 0.16
• Cash Flow: $0.30 per share
• Price / Cash Flow: 4.46
• Book Value: $1.35 per share
• Price / Book: 1.01

Miscellaneous

• Outstanding Shares: 21,680,000
• Free Float: 21,397,000
• Market Cap: $29.48 million
• Optionable: Optionable
• Beta: 0.83